NCT05812781: An ongoing trial by Zomagen Biosciences, Ltd
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 2 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05812781 |
|---|---|
| Title | A Phase 2A, Single-Arm Study to Evaluate the Safety and Clinical Activity of VTX2735 in Participants With Cryopyrin-Associated Periodic Syndrome (CAPS) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 18, 2023 |
| Completion date | March 6, 2024 |
| Required reporting date | March 6, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |